[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Advice from Peter
- To: <liblicense-l@lists.yale.edu>, <Karl.Bridges@uvm.edu>, <pbanks@diabetes.org>
- Subject: RE: Advice from Peter
- From: "David Goodman" <David.Goodman@liu.edu>
- Date: Fri, 11 Nov 2005 16:57:08 EST
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
Peter, Do you mean discussions of pricing, discussions giving specific prices and detail of contracts, or discussions of the advisability or legality of having such discussions. You give an opinion about the legality of private discussions at a meeting. But I believe Karl was asking about public discussion at a meeting. I, and you, have been at many a meeting where publishers presented openly their pricing structure, generally for the purpose of trying to convince prospective purchasers that they were getting a fair deal. At any rate, I suggest that it is exactly the private arrangements behind a closed door that are likely to be anticompetitive. And I remember the title of the precursor to this list on the web, the "Newsletter on Serials Pricing issues." Extending your theory, is it legal to post a price list on the web, as most publishers do? Another publisher could use this information for such purposes as not charging a higher price for similar material. I have frequently given advice on pricing on this and other lists, in various periodicals, and in many open and private conversations, and so have many others. I'm not a lawyer, as is obvious, but perhaps Peter is using the legal structure that prohibits anticompetitive practices to prohibit the discussion of pro-competitive practices. Dr. David Goodman Associate Professor Palmer School of Library and Information Science Long Island University dgoodman@liu.edu -----Original Message----- From: owner-liblicense-l@lists.yale.edu on behalf of Peter Banks Sent: Thu 11/10/2005 9:36 PM To: Karl.Bridges@uvm.edu Subject: Re: Response from Ted Bergstrom to Ann Okerson Please don't make this into a publisher conspiracy. I was making the point for the sake of participants in this list serve--and Ann especially, whose neck is on the line. You should not discuss pricing on any listserve, on any subject. If you doubt me, ask your attorney. What happens in private conversations at meetings is your business. Peter Banks Acting Vice President for Publications/Publisher American Diabetes Association Email: pbanks@diabetes.org >>> Karl Bridges <Karl.Bridges@uvm.edu> 11/10/05 5:18 AM >>> I guess this leads to my next question. If it's a problem to discuss this in a listserv why are people doing it at conferences and why, if that happened, did not the publishers in the room complain about it? Quoting Peter Banks <pbanks@diabetes.org>: > It definitely is potential restraint of trade--and dicussion of pricing > on this, or any, list-serve, would be very unwise (most moderators slap > the hands of those who even hint at discussion of pricing). > > Peter Banks > American Diabetes Association > Email: pbanks@diabetes.org
- Prev by Date: Press Release: NHS ENGLAND EXTEND BIOMED CENTRAL MEMBERSHIP TO 2008
- Next by Date: Re: Secret pricing (RE: Response from Ted Bergstrom to Ann Okerson)
- Previous by thread: Press Release: NHS ENGLAND EXTEND BIOMED CENTRAL MEMBERSHIP TO 2008
- Next by thread: RE: Advice from Peter
- Index(es):